Importance Myelin oligodendrocyte glycoprotein-IgG1–associated disorder (MOGAD) is a
distinct central nervous system–demyelinating disease. Positive results on MOG-IgG1 testing …

Objective To determine clinical manifestations, immunotherapy responsiveness and outcomes
of glutamic acid decarboxylase-65 (GAD65) neurological autoimmunity. Methods We …

E530 CMAJ| MAY 13, 2019| VOLUME 191| ISSUE 19 paroxysmal dizziness spells, but
faciobrachial dystonic seizures are especially helpful diagnostically as they are nearly …

Background Autoimmunity is an increasingly recognized cause of encephalitis with a similar
prevalence to that of infectious etiologies. Over the past decade there has been a rapidly …

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory
demyelinating disease that is distinct from multiple sclerosis. Initial manifestations of …

Cerebral cortical encephalitis (CCE) is a recently described myelin oligodendrocyte glycoprotein
antibody‐associated disease (MOGAD) phenotype. In this observational retrospective …

Background: The gut microbiome, which consists of a highly diverse ecologic community of
micro-organisms, has increasingly been studied regarding its role in multiple sclerosis (MS) …

A plethora of antibodies against neural antigens have emerged as biomarkers of autoimmune
encephalitis. This has led to a rise in neural antibody testing among patients suspected of …

Objective To compare specificity and sensitivity of a commercially available fixed cell-based
assay (F-CBA) to radioimmunoprecipitation assay (RIPA) for acetylcholine receptor antibody …

Objective Numerous predictive scores have been developed to help determine which patients
with epilepsy or seizures of unknown etiology should undergo neural antibody testing. …